These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 23889344)

  • 1. Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
    Pozzi S; Marcheselli L; Bari A; Liardo EV; Marcheselli R; Luminari S; Quaresima M; Cirilli C; Ferri P; Federico M; Sacchi S
    Br J Haematol; 2013 Oct; 163(1):40-6. PubMed ID: 23889344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and survival of multiple myeloma: a population-based study of 10 524 patients diagnosed 1982-2017.
    Langseth ØO; Myklebust TÅ; Johannesen TB; Hjertner Ø; Waage A
    Br J Haematol; 2020 Nov; 191(3):418-425. PubMed ID: 32367512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment.
    Powles R; Raje N; Milan S; Millar B; Shepherd V; Mehta J; Singhal S; Kulkarni S; Viner C; Gore M; Cunningham D; Treleaven J
    Bone Marrow Transplant; 1997 Sep; 20(6):435-43. PubMed ID: 9313875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study.
    Turesson I; Velez R; Kristinsson SY; Landgren O
    J Clin Oncol; 2010 Feb; 28(5):830-4. PubMed ID: 20038719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003.
    Kristinsson SY; Landgren O; Dickman PW; Derolf AR; Björkholm M
    J Clin Oncol; 2007 May; 25(15):1993-9. PubMed ID: 17420512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved survival of older patients with multiple myeloma in the era of novel agents.
    Mey UJ; Leitner C; Driessen C; Cathomas R; Klingbiel D; Hitz F
    Hematol Oncol; 2016 Dec; 34(4):217-223. PubMed ID: 25898820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and survival outcomes in patients with multiple myeloma: analysis of web-based data from the Korean Myeloma Registry.
    Kim SJ; Kim K; Kim BS; Jo DY; Kang HJ; Kim JS; Mun YC; Kim CS; Sohn SK; Eom HS; Kwak JY; Shim H; Yoon HJ; Jin JY; Min CK; Shin H; Won JH; Lee JJ; Kwon JH; Joo YD; Do YR; Kim SH; Oh S; Suh C; Lee J; Yoon SS; Kim MK; Bang SM; Ryoo HM; Kim BS; Kim H; Kim HJ; Kim YS; Park CW; Lee GW; Shin HJ; Park SK; Park JS; Kim HY; Lee DS; Lee JH;
    Acta Haematol; 2009; 122(4):200-10. PubMed ID: 19887776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival.
    Palumbo A; Attal M; Roussel M
    Clin Cancer Res; 2011 Mar; 17(6):1253-63. PubMed ID: 21411441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age disparities in survival from lymphoma and myeloma: a comparison between US and England.
    Pulte D; Redaniel MT; Lowry L; Bird J; Jeffreys M
    Br J Haematol; 2014 Jun; 165(6):824-31. PubMed ID: 24684252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.
    Child JA; Morgan GJ; Davies FE; Owen RG; Bell SE; Hawkins K; Brown J; Drayson MT; Selby PJ;
    N Engl J Med; 2003 May; 348(19):1875-83. PubMed ID: 12736280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.
    Thorsteinsdottir S; Dickman PW; Landgren O; Blimark C; Hultcrantz M; Turesson I; Björkholm M; Kristinsson SY
    Haematologica; 2018 Sep; 103(9):e412-e415. PubMed ID: 29567776
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple myeloma in north east Scotland: a review of incidence and survival over three decades.
    Soutar RL; Dawson AA; Wilson BJ
    Health Bull (Edinb); 1996 May; 54(3):232-40. PubMed ID: 8707567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multiple myeloma.
    San Miguel JF; Bladé Creixenti J; García-Sanz R
    Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
    Dimopoulos MA; Kastritis E; Delimpasi S; Katodritou E; Hatzimichael E; Kyrtsonis MC; Repousis P; Tsirogianni M; Kartasis Z; Parcharidou A; Michael M; Michalis E; Tsatalas C; Stefanoudaki E; Hatjiharissi E; Gika D; Symeonidis A; Terpos E; Zervas K;
    Eur J Haematol; 2012 Jul; 89(1):10-5. PubMed ID: 22469521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world epidemiology, treatment patterns and survival of multiple myeloma patients in a large nationwide health plan.
    Weil C; Gelerstein S; Sharman Moser S; Chodick G; Barit Ben-David N; Shalev V; Shofaniyeh I; Kamalov R; Meytes D
    Leuk Res; 2019 Oct; 85():106219. PubMed ID: 31473468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period.
    Rodríguez-Lobato LG; Pereira A; Fernández de Larrea C; Cibeira MT; Tovar N; Jiménez-Segura R; Moreno DF; Oliver-Caldés A; Rosiñol L; Bladé J
    Br J Haematol; 2022 Feb; 196(3):649-659. PubMed ID: 34622447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
    Klepin HD; Hurd DD
    Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support.
    Vogl DT; Liu SV; Chong EA; Luger SM; Porter DL; Schuster SJ; Tsai DE; Perl A; Loren AW; Goldstein SC; Nasta SD; Andreadis C; Mangan PA; Hummel K; Siegel DL; Glatstein E; Stadtmauer EA
    Am J Hematol; 2007 Dec; 82(12):1071-5. PubMed ID: 17696204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.